CD4 and glioblastoma: In a logistic regression model, newly diagnosed PrEP users had 2.6-times (95% CI: 1.2, 6.4) higher odds of clustering compared to non-PrEP users, adjusted for GBM, age at first ART, and baseline CD4 count.